Bdc Capital Inc. - Net Worth and Insider Trading
Bdc Capital Inc. Net Worth
The estimated net worth of Bdc Capital Inc. is at least $4 Million dollars as of 2024-09-29. Bdc Capital Inc. is the 10% Owner of Milestone Pharmaceuticals Inc and owns about 2,388,088 shares of Milestone Pharmaceuticals Inc (MIST) stock worth over $4 Million. Details can be seen in Bdc Capital Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bdc Capital Inc. has not made any transactions after 2019-05-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bdc Capital Inc.
Bdc Capital Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bdc Capital Inc. owns 2 companies in total, including Milestone Pharmaceuticals Inc (MIST) , and Ocera Therapeutics Inc (OCRX) .
Click here to see the complete history of Bdc Capital Inc.’s form 4 insider trades.
Insider Ownership Summary of Bdc Capital Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MIST | Milestone Pharmaceuticals Inc | 2019-05-08 | 10 percent owner |
| OCRX | Ocera Therapeutics Inc | 2011-04-06 | 10 percent owner |
Bdc Capital Inc. Latest Holdings Summary
Bdc Capital Inc. currently owns a total of 1 stock. Bdc Capital Inc. owns 2,388,088 shares of Milestone Pharmaceuticals Inc (MIST) as of May 8, 2019, with a value of $4 Million.
Latest Holdings of Bdc Capital Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MIST | Milestone Pharmaceuticals Inc | 2019-05-08 | 2,388,088 | 1.53 | 3,653,775 |
Holding Weightings of Bdc Capital Inc.
Bdc Capital Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Bdc Capital Inc. has made a total of 0 transactions in Milestone Pharmaceuticals Inc (MIST) over the past 5 years. The most-recent trade in Milestone Pharmaceuticals Inc is the acquisition of 200,000 shares on May 8, 2019, which cost Bdc Capital Inc. around $3 Million.
Insider Trading History of Bdc Capital Inc.
- 1
Bdc Capital Inc. Trading Performance
Bdc Capital Inc. Ownership Network
Bdc Capital Inc. Owned Company Details
What does Milestone Pharmaceuticals Inc do?
Who are the key executives at Milestone Pharmaceuticals Inc?
Bdc Capital Inc. is the 10 percent owner of Milestone Pharmaceuticals Inc. Other key executives at Milestone Pharmaceuticals Inc include Chief Medical Officer David Bharucha , 10 percent owner Roderick Wong , and 10 percent owner Rtw Investments, Lp .
Milestone Pharmaceuticals Inc (MIST) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Milestone Pharmaceuticals Inc (MIST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Milestone Pharmaceuticals Inc (MIST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Milestone Pharmaceuticals Inc (MIST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Milestone Pharmaceuticals Inc Insider Transactions
Bdc Capital Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Bdc Capital Inc.. You might contact Bdc Capital Inc. via mailing address: Suite 300, 5 Place Ville Marie, Montreal A8 H3b 5e7.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
